US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.010
  • -0.350-5.50%
Close May 10 16:00 ET
  • 6.039
  • +0.029+0.49%
Post 19:29 ET
504.63MMarket Cap-2094P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

5.70M

+305.63%
EPS(YoY)

-0.59

+29.76%
Analyst Rating

Strong Buy

May 9, 2024

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.060M--
--2024/Q2-- / 3.485M--
--2024/Q15.695M / 2.250M--
--2023/Q45.143M / 1.167M--
--2023/Q33.117M / 1.084M--
--2023/Q22.093M / 672.670K--
May 15, 20232023/Q11.404M / 514.290K--
--2022/Q41.012M / 442.860K--
--2022/Q3929.000K / 833.330K--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.060M--
--2024/Q2-- / 3.485M--
--2024/Q15.695M / 2.250M--
--2023/Q45.143M / 1.167M--
--2023/Q33.117M / 1.084M--
--2023/Q22.093M / 672.670K--
May 15, 20232023/Q11.404M / 514.290K--
--2022/Q41.012M / 442.860K--
--2022/Q3929.000K / 833.330K--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

  • Verve Therapeutics | 10-Q: Quarterly report

    May 8 19:33

  • Verve Therapeutics | 10-K: Annual report

    Feb 27 21:05

  • Verve Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 20:30

  • Verve Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 19:30

    • Read more

    Analysis

    Analyst Rating

    Updated: May 9, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg